Evaluation of Etanercept Treatment in Newborn Rat Model with Hyperoxic Lung Injury

References

• Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics. 2001;107(1):e1.
   Google Scholar
• Carraro S, Filippone M, Da Dalt L, et al. Bronchopulmonary dysplasia: the earliest and perhaps the longest lasting obstructive lung disease in humans. Early Hum Dev. 2013;89:3–5.
   Web of Science ®Google Scholar
• vom Hove M, Prenzel F, Uhlig HH, Robel-Tillig E. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case–control follow-up at school age. J Pediatr. 2014;164(1):40–5.e4.
   PubMed Web of Science ®Google Scholar
• Baraldi E, Filippone M. Chronic lung disease after premature birth. N Eng J Med. 2007;357(19):1946–55.
   PubMed Web of Science ®Google Scholar
• Northway Jr WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Eng J Med. 1967;276(7):357–68.
   PubMed Web of Science ®Google Scholar
• Gonzalez A, Sosenko IR, Chandar J, Hummler H, Claure N, Bancalari E. Influence of infection on patent ductusarteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr. 1996;128(4):470–8.
   PubMed Web of Science ®Google Scholar
• Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116(6):1353–60.
   PubMed Web of Science ®Google Scholar
• Bourbia A, Cruz MA, Rozycki HJ. NF-kappaB in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome. Arch Dis Child Fetal Neonatal Ed. 2006;91(1):36–9.
   Web of Science ®Google Scholar
• Bhatt AJ, Pryhuber GS, Huyk H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;164(10):1971–80.
   PubMed Web of Science ®Google Scholar
• Köksal N, Kayık B, Çetinkaya M, et al. Value of serum and bronchoalveolar fluid lavage pro-and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants. Eur Cytokine Netw. 2012;23(2):29–35.
   PubMed Web of Science ®Google Scholar
• Bose CL, Dammann CE, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed. 2008;93(6):455–61.
   Web of Science ®Google Scholar
• Corso AL PP, Pitrez PM, Machado DC, Stein RT, Jones MH. TNF-alpha and IL-10 levels in tracheobronchial lavage of ventilated preterm infants and subsequent lung function. Braz J Med Biol Res. 2007;40(4):569–76.
   PubMed Web of Science ®Google Scholar
• Feldmann M, Maini RN. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med. 2003;9(10):1245–50.
   PubMed Web of Science ®Google Scholar
• Natarajan G, Pappas A, Shankaran S, et al. Outcomes of extremely low birth weight infants with bronchopulmonary dysplasia: impact of the physiologic definition. Early Hum Dev. 2012;88(7):509–15.
   PubMed Web of Science ®Google Scholar
• Warner BB, Stuart LA, Papes RA, Wispé JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol. 1998;275(1):110–7.
   Google Scholar
• Ozdulger A, Cinel I, Koksel O, et al. The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock. 2003;19(4):366–72.
   PubMed Web of Science ®Google Scholar
• Askenazi SS, Perlman M. Pulmonary hypoplasia: lung weight and radial alveolar count as criteria of diagnosis. Arch Dis Child. 1979;54(8):614–8.
   PubMed Web of Science ®Google Scholar
• Harding R, Hooper SB. Regulation of lung expansion and lung growth before birth. J Appl Physiol. 1996;81(1):209–24.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–75.
   PubMed Web of Science ®Google Scholar
• Kazzi SN, Kim UO, Quasney MW, Buhimschi I. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics. 2004;114(2):243–8.
   Web of Science ®Google Scholar
• Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 1997;177(1):19–26.
   PubMed Web of Science ®Google Scholar
• Kazzi SNJ, Tromp G, Quasney MW, Buhimschi IA. Haplotypes of tumor necrosis factor gene and tracheal aspirate fluid levels of tumor necrosis actor-alpha in preterm infants. Pediatr Res. 2008;64(2):165–70.
   PubMed Web of Science ®Google Scholar
• Cetinkaya M, Cansev M, Kafa IM, et al. Cytidine 5 [prime]-diphosphocholine ameliorates hyperoxic lung injury in a neonatal rat model. Pediatr Res. 2013;74(1):26–33.
   PubMed Web of Science ®Google Scholar
• Jensen JC, Pogrebniak HW, Pass HI, et al. Role of tumor necrosis factor in oxygen toxicity. J Applied Physiol. 1992;72(5):1902–7.
   PubMed Web of Science ®Google Scholar
• Tsan MF, White JE, Michelsen PB, Wong GH. Pulmonary O2 toxicity: role of endogenous tumor necrosis factor. Exp Lung Res. 1995;21(4):589–97.
   PubMed Web of Science ®Google Scholar
• Guthmann F, Wissel H, Schachtrup C, et al. Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells. Respir Res. 2005;6(10):1–16.
   PubMed Web of Science ®Google Scholar
• Guthmann F, Wissel H, Rüstow B. Early subcutaneous administration of etanercept (Enbrel) prevents from hyperoxia-induced lung injury. Exp Lung Res. 2009;35(9):770–80.
   PubMed Web of Science ®Google Scholar
• Tayman C, Cekmez F, Kafa I M, et al. Protective effects of Nigella sativa oil in hyperoxia-induced lung injury. Arch Bronconeumol (English Edition). 2013;49(1):15–21.
   Google Scholar
• Albertine KH, Plopper CG. DNA oxidation or apoptosis: will the real culprit of dna damage in hyperoxic lung injury please stand up? Am J Respir Cell Mol Biol. 2002;26(4):381–3.
   PubMed Web of Science ®Google Scholar
• Romero FJ, Bosch-Morell F, Romero MJ, et al. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect. 1998;106(Suppl 5):1229–34.
   PubMed Web of Science ®Google Scholar
• Valenzuela A. The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. Life Sci. 1991;48(4):301–9.
   PubMed Web of Science ®Google Scholar
• Saugstad OD. Bronchopulmonary dysplasia—oxidative stress and antioxidants. Semin Neonatol. 2003;8(1):39–49.
   PubMedGoogle Scholar
• Lee JW, Davis JM. Future applications of antioxidants in premature infants. Curr Opin in Pediatr. 2011;23(2):161–6.
   PubMed Web of Science ®Google Scholar
• Pryhuber GS, O'Brien DP, Baggs R, et al. Ablation of tumor necrosis factor receptor type I (p55) alters oxygen-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2000;278(5):L1082–90.
   Google Scholar
• Dieperink HI, Blackwell TS, Prince LS. Hyperoxia and apoptosis in developing mouse lung mesenchyme. Pediatr Res. 2006;59(2):185–90.
   PubMed Web of Science ®Google Scholar
• Vancurova I, Bellani P, Davidson D. Activation of nuclear factor-kappaB and its suppression by dexamethasone in polymorphonuclear leukocytes: newborn versus adult. Pediatr Res. 2001;49(2):257–62.
   PubMed Web of Science ®Google Scholar
• Lories R, Derese I, Luyten F, De Vlam K. Activation of nuclear factor kappa B and mitogen activated protein kinases in psoriatic arthritis before and after etanercept treatment. Clin Exp Rheumatol. 2008;26(1):96–102.
   PubMed Web of Science ®Google Scholar
• Held H-D, Boettcher S, Hamann L, Uhlig S. Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-κ B and is blocked by steroids. Am J Respir Crit Care Med. 2001;163(3):711–6.
   PubMed Web of Science ®Google Scholar
• Lassus P, Turanlahti M, Heikkila PI, et al. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med. 2001;164(10):1981–7.
   PubMed Web of Science ®Google Scholar
• Holmes-McNary MQ, Baldwin AS, Zeisel SH. Opposing regulation of choline deficiency-induced apoptosis by p53 and nuclear factor kappaB. J of Biol Chem. 2001;276(44):41197–204.
   PubMed Web of Science ®Google Scholar